Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children.
about
Virologic response in children treated with abacavir-compared with stavudine-based antiretroviral treatment: a South African multi-cohort analysisImpact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents.Antiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomes.Prevalence of pain and association with psychiatric symptom severity in perinatally HIV-infected children as compared to controls living in HIV-affected householdsIncreased risk of asthma and atopic dermatitis in perinatally HIV-infected children and adolescents.HIV-Antiretroviral Therapy Induced Liver, Gastrointestinal, and Pancreatic Injury.Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.Antiretrovirals, Methamphetamine, and HIV-1 Envelope Protein gp120 Compromise Neuronal Energy Homeostasis in Association with Various Degrees of Synaptic and Neuritic DamageThe impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1Pharmacotherapy of pediatric and adolescent HIV infectionNeuronal Stress and Injury Caused by HIV-1, cART and Drug Abuse: Converging Contributions to HAND.Pediatric antiretroviral therapy.Developments in early diagnosis and therapy of HIV infection in newborns.CYP1A1m1 and CYP2C9*2 and *3 polymorphism and risk to develop ARV-associated hepatotoxicity and its severity.Impact of GSTM1, GSTT1 and GSTP1 gene polymorphism and risk of ARV-associated hepatotoxicity in HIV-infected individuals and its modulation.Occurrence of stavudine-induced lactic acidosis in 3 members of an African family.Peripheral neuropathy in children on stauvudine therapy.Neuropathic pain in children.IL-1RN and IL-1β Polymorphism and ARV-Associated Hepatotoxicity.HIV Reverse Transcriptase InhibitorsUsing Observational Data to Inform HIV Policy Change for Children and Youth
P2860
Q33624953-E3A80F91-B389-41DD-884C-8FB563787E0DQ33650149-50F556D5-9F76-4D78-B56B-50F923191963Q35074791-2FC3C17B-4775-4040-91A3-E13472BC27C2Q35166067-B9CFC468-378B-460D-B82C-95CA766B4645Q35740081-0DBF4992-3645-46D7-A4E7-EF7BB053AAF5Q35852627-F25F4AE2-2EB5-49ED-9998-553C5D61E084Q36438846-AE37B422-82AE-48AC-AA2F-B9F6F496BFB4Q36439056-34CA056D-5FE0-431B-9EC3-283B513258D2Q36441790-A238D3D2-5090-482C-B148-E19455FBB127Q37240305-7E316DAA-F4C8-42F4-AB5E-F38D9B7A2F7FQ37721505-54034041-1E3A-4232-9E2F-C29547601D83Q37816389-E85D9653-8A6F-488C-9518-567AE538E417Q38648601-B42529D1-4564-4C29-AE7A-70558631D7B3Q40267083-64052CAC-51A5-435A-B270-6F8A9AFAFA34Q40871154-D765F0A1-3C4B-47F0-BB5F-D5833FACB72EQ42924601-DFBDDDA6-F9DF-4331-AB01-FFF265FB6C26Q43456653-5D278ECF-1E71-4D92-896C-4DEABC7CADC8Q44688179-28093E81-70F9-483D-93D4-4637012AF4D1Q55001956-E4E93258-1D0A-45D1-B05B-842EA55EC830Q56786269-36F9DE38-B7EA-436B-A256-8EBB1124C6D2Q56888618-20F937C1-FC54-4DFF-ABBC-BBF60E8A2F7D
P2860
Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Toxicities associated with dua ...... mens in HIV-infected children.
@ast
Toxicities associated with dua ...... mens in HIV-infected children.
@en
type
label
Toxicities associated with dua ...... mens in HIV-infected children.
@ast
Toxicities associated with dua ...... mens in HIV-infected children.
@en
prefLabel
Toxicities associated with dua ...... mens in HIV-infected children.
@ast
Toxicities associated with dua ...... mens in HIV-infected children.
@en
P2093
P2860
P356
P1476
Toxicities associated with dua ...... mens in HIV-infected children.
@en
P2093
Paige L Williams
Pediatric AIDS Clinical Trials Group 219C Team
Russell B Van Dyke
P2860
P304
P356
10.1086/593022
P407
P577
2008-12-01T00:00:00Z